Juvenile Idiopathic Arthritis (JIA) Treatments

Find Juvenile Idiopathic Arthritis (JIA) Treatments

Generic Name

Tocilizumab

Brand Names
Tocilizumab-anoh, Tyenne, Actemra ACTPen, Avtozma, Tofidence, Actemra
FDA approval date: January 08, 2010
Classification: Interleukin-6 Receptor Antagonist
Form: Injection

What is Tocilizumab-anoh (Tocilizumab)?

TYENNE ® is an interleukin-6 receptor antagonist indicated for treatment of: Rheumatoid Arthritis .
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

Summary: This study is an open-label, randomized, multicenter trial that incorporates a multi-arm design comparing each of 3 non-TNFi (Tumor Necrosis Factor inhibitor) medications to a second TNFi (active control) within a sequential multiple assignment randomized trial design with 2 randomization stages corresponding with clinical decision points. The first randomization addresses whether each of the 3 no...

An Open-label, Multicenter, Dose Escalation, First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered RO7507062 in Participants With Systemic Lupus Erythematosus

Summary: The purpose of this study is to investigate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of RO7507062 in participants with systemic lupus erythematosus (SLE). The study will have 2 parts: Part 1 is a single ascending dose-finding (SAD) part and Part 2 is a dose escalation with fractionated dosing part.

A Phase 1b/2 Open-label Study Evaluating Different MK-6070 and Ifinatamab Deruxtecan (MK-2400)-Based Regimens in First-line Extensive Stage Small Cell Lung Cancer

Summary: Researchers are looking for new ways to treat extensive-stage small cell lung cancer (ES-SCLC). ES-SCLC is a type of lung cancer that has spread throughout the lung, to the other lung, or to other parts of the body. A standard (usual) treatment for ES-SCLC uses both chemotherapy and immunotherapy. * Chemotherapy is a treatment that works to destroy cancer cells or stop them from growing. * Immunot...

Brand Information